 Montreal-based Sunshine Biopharma stock tripled to 6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells. The post Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results appeared first on InvestorPlace. 